OptionsHouse

Options Trading News

November 13, 2013  Wed 9:30 AM CT

TEVA: SEE CHART GET CHAIN FIND STRATEGIES
As Teva Pharmaceutical tries to recover from a steep selloff last month, one trader apparently believes that any further downside will be limited.

optionMONSTER's tracking systems detected the sale of 5,000 December 35 puts in one print for the bid price of $0.22 this morning. The volume is above previous open interest in the strike, indicating that it is a new position.

The trader will keep the $0.22 credit as profit if TEVA remains above $35 through expiration in mid-December. But if the stock falls below that strike price, he or she will be on the hook to buy shares at that level. (See our Education section)

TEVA is up 0.64 percent to $37.99 in morning trading. The drug developer gapped down from $41 after its CEO resigned unexpectedly late last month, but shares bounced near the $36 level a week later and have been drifting higher since. 
Share this article with your friends


Related Stories

TEVA

Can anything stop Teva Pharma?

April 13, 2015

Traders began making long-term bullish bets on the drug maker in early March as the stock traded in a tight range, and the stock has since taken off.

TEVA

Cramer: I repeat, specialty pharma

April 10, 2015

Certain specialty pharma names will stay loved as long as they have much faster growth than the traditional companies in the industry in a time when growth remains very hard to come by.

OptionsHouse

Premium Services

Education & Strategy

Vega

There is another Greek which measures the effects on an option's price buy changing the amount of extrinsic value in the option, and that Greek is Vega...

View more education articles »